Nicholas Baxter - May 15, 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Nicholas Baxter/
Stock symbol
LEXX
Transactions as of
May 15, 2025
Transactions value $
$0
Form type
4
Date filed
5/16/2025, 04:40 PM
Previous filing
Jul 30, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baxter Nicholas W Director 37H KING'S GATE, ABERDEEN, ABERDEENSHIRE, SCOTLAND, UNITED KINGDOM /Nicholas Baxter/ 2025-05-16 0001312326

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 11K May 15, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +11K +21.15% $0.00 63K May 15, 2025 Common Shares 11K $1.04 Direct
holding LEXX Stock Options 1.5K May 15, 2025 Common Shares 1.5K $3.00 Direct
holding LEXX Stock Options 6.5K May 15, 2025 Common Shares 5K $3.00 Direct
holding LEXX Stock Options 8.4K May 15, 2025 Common Shares 1.9K $3.00 Direct
holding LEXX Stock Options 11.8K May 15, 2025 Common Shares 3.4K $3.39 Direct
holding LEXX Stock Options 30K May 15, 2025 Common Shares 18.2K $1.96 Direct
holding LEXX Stock Options 35K May 15, 2025 Common Shares 5K $0.87 Direct
holding LEXX Stock Options 40K May 15, 2025 Common Shares 5K $2.36 Direct
holding LEXX Stock Options 52K May 15, 2025 Common Shares 12K $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.